MedPath

Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence

Phase 4
Withdrawn
Conditions
Stress Urinary Incontinence
Interventions
Procedure: Laparoscopic Burch colposuspension
Procedure: Transobturator tape procedure
Registration Number
NCT00573703
Lead Sponsor
University Magna Graecia
Brief Summary

Transobturatory tape (TOT) procedure is a minimally invasive approach to urinary stress incontinence owing to the category of the sling-adopting procedures. Its efficacy and safety, also in comparison with similar procedures have been demonstrated. The benefits of the sling- adopting procedures in comparison to laparoscopic Burch colposuspension, which has been considered as the gold standard treatment, have been showed. But these comparisons did not included the TOT procedure in the experimental arms. Based on this considerations the aim of this trial will be to compare TOT and laparoscopic Burch colposuspension in women with urinary stress incontinence.

Detailed Description

Women with predominant and genuine stress urinary incontinence will be enrolled and randomized in two groups (groups A and B). Patients of group A will be treated with laparoscopic Burch colposuspension, whereas patients of group B will be treated with TOT procedure.

All patients eligible will undergo baseline assessment consisting of anthropometric, clinical, hormonal, urodynamic, and ultrasonographic evaluations. During the study, the surgical outcomes, the clinical subjective and objective efficacy data, and the adverse experiences will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Predominant or genuine stress urinary incontinence by self report,examination and test
  • Urethral hypermobility
  • Eligible for both surgical procedures
  • Ambulatory
Exclusion Criteria
  • Pregnancy
  • <12 months post-partum
  • Systemic disease and/or drugs known to affect bladder function
  • Current chemotherapy or radiation therapy
  • Urethral diverticulum, augmentation cytoplasty, or artificial sphincter
  • Recent pelvic surgery
  • Severe genuine stress incontinence (loss of urine with minimal physical activity) with associated prolapse equal to or more than second degree
  • Previous pelvic or anti-incontinence surgery
  • History of severe abdominopelvic infections
  • Known extensive abdominopelvic adhesions
  • Detrusor instability and/or intrinsic sphincter dysfunction
  • Other gynaecologic pathologies (eg, fibroids, ovarian cysts)
  • BMI >30

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group ALaparoscopic Burch colposuspension-
Group BTransobturator tape procedure-
Primary Outcome Measures
NameTimeMethod
Objective/subjective symptoms improvements12 months
Secondary Outcome Measures
NameTimeMethod
Failure rate12 months
Recurrence rate12 months
Quality of life12 months
Sexual function12 months
Intra-operative complication rateone day
Postoperative complications rate12 months

Trial Locations

Locations (1)

"Pugliese" Hospital

馃嚠馃嚬

Catanzaro, Italy

漏 Copyright 2025. All Rights Reserved by MedPath